Supplement: Cancer Immunotherapies Development Barriers
Current State of Protocol Design Impacting Small to Mid-Sized Biotech Companies
Supplement: Novel Cancer Immunotherapy Combos
Researchers Contextualize Immuno-Oncology Mechanisms to Advance Personalized Therapies
New Group Promotes AI, Robotics, and Automation in Healthcare
Goal Is to Improve Patient Access to Quality Care
Playing Catch-Up with Optogenetic Effects
Optogenetically Triggered Processes Needn’t Become Visualization and Mapping Blurs
For full access to this article login to GEN Select now.
High-Content Analysis Has Full Dance Card
Phenotypic Screening Is Being Paired With a Succession of Complementary Technologies
- As its image processing and memory capabilities keep improving, high-content analysis (HCA) is emerging as a formidable—and flexible—innovation platform. HCA is being partnered with three-dimensional (3D) cell culture, whole-animal models, systems biology, and genetic editing to drive discovery in basic research and clinical medicine. For example, various combinations ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.